Dogwood Therapeutics, Inc. (DWTX) Operating income 2020–2025
Dogwood Therapeutics, Inc. (DWTX) annual operating income history from SEC filings — each fiscal year as reported.
-$28.0MFY2025 · since FY2020: -$10.0M → -$28.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.0M | -128.7% |
| FY2024 | -$12.2M | -124.5% |
| FY2023 | -$5.4M | +55.8% |
| FY2022 | -$12.3M | +21.3% |
| FY2021 | -$15.6M | -56.3% |
| FY2020 | -$10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice